Again, more news within the last month:
"...HERZLIYA, Israel, Jan 29, 2007 (BUSINESS WIRE) --
Tissera, Inc. (OTCBB:TSSR) reports that Prof. Yair Reisner and his research team from the Weizmann Institute of Science published an article in the December 12, 2006 issue of PNAS (Proceedings of the National Academy of Sciences) entitled "Correcting Monogenic Diseases by Fetal Spleen Transplantation: Hemophilia as a Proof of Concept". The study may be obtained in PDF form from the PNAS website, www.pnas.org.
The team's research was predominantly supported by Tissera as part of its Research and Development Plan, which is based on the premise that ways might be found to utilize various porcine fetal tissues for transplantation into human patients in need. The Company's R&D efforts are directed towards developing and commercializing such transplantation technology, which has the potential to provide a universally available and reliable source of transplantable organs and alleviate the current severe shortage of donor organs.
Efforts have focused on several applications, such as the use of embryonic pancreas tissue for the treatment of insulin-dependent diabetes mellitus, and liver and spleen for the treatment of monogenic enzymatic deficiencies..."
Anyone here knows about this company?
At the end od October, the shares jumped over .10 to a peak over .20 in early December. As you can see now, TSSR is back under .12.
Comments or information would be appreciated.
alen |
